These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12473505)

  • 1. Prostate-cancer screening targets men with BRCA mutations.
    Bonn D
    Lancet Oncol; 2002 Dec; 3(12):714. PubMed ID: 12473505
    [No Abstract]   [Full Text] [Related]  

  • 2. Germline BRCA mutations denote a clinicopathologic subset of prostate cancer.
    Gallagher DJ; Gaudet MM; Pal P; Kirchhoff T; Balistreri L; Vora K; Bhatia J; Stadler Z; Fine SW; Reuter V; Zelefsky M; Morris MJ; Scher HI; Klein RJ; Norton L; Eastham JA; Scardino PT; Robson ME; Offit K
    Clin Cancer Res; 2010 Apr; 16(7):2115-21. PubMed ID: 20215531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study.
    Mitra AV; Bancroft EK; Barbachano Y; Page EC; Foster CS; Jameson C; Mitchell G; Lindeman GJ; Stapleton A; Suthers G; Evans DG; Cruger D; Blanco I; Mercer C; Kirk J; Maehle L; Hodgson S; Walker L; Izatt L; Douglas F; Tucker K; Dorkins H; Clowes V; Male A; Donaldson A; Brewer C; Doherty R; Bulman B; Osther PJ; Salinas M; Eccles D; Axcrona K; Jobson I; Newcombe B; Cybulski C; Rubinstein WS; Buys S; Townshend S; Friedman E; Domchek S; Ramon Y Cajal T; Spigelman A; Teo SH; Nicolai N; Aaronson N; Ardern-Jones A; Bangma C; Dearnaley D; Eyfjord J; Falconer A; Grönberg H; Hamdy F; Johannsson O; Khoo V; Kote-Jarai Z; Lilja H; Lubinski J; Melia J; Moynihan C; Peock S; Rennert G; Schröder F; Sibley P; Suri M; Wilson P; Bignon YJ; Strom S; Tischkowitz M; Liljegren A; Ilencikova D; Abele A; Kyriacou K; van Asperen C; Kiemeney L; ; Easton DF; Eeles RA
    BJU Int; 2011 Jan; 107(1):28-39. PubMed ID: 20840664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRCA1 and BRCA2 mutations have no major role in predisposition to prostate cancer in Finland.
    Ikonen T; Matikainen MP; Syrjäkoski K; Mononen N; Koivisto PA; Rökman A; Seppälä EH; Kallioniemi OP; Tammela TL; Schleutker J
    J Med Genet; 2003 Aug; 40(8):e98. PubMed ID: 12920090
    [No Abstract]   [Full Text] [Related]  

  • 5. Founder mutations in BRCA1/2 are not frequent in Canadian Ashkenazi Jewish men with prostate cancer.
    Hamel N; Kotar K; Foulkes WD
    BMC Med Genet; 2003 Aug; 4():7. PubMed ID: 12911837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prostate cancer and DNA repair genes].
    Penel N
    Bull Cancer; 2017 Nov; 104(11):958-961. PubMed ID: 29032803
    [No Abstract]   [Full Text] [Related]  

  • 7. The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. The Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study Collaborators.
    Gayther SA; de Foy KA; Harrington P; Pharoah P; Dunsmuir WD; Edwards SM; Gillett C; Ardern-Jones A; Dearnaley DP; Easton DF; Ford D; Shearer RJ; Kirby RS; Dowe AL; Kelly J; Stratton MR; Ponder BA; Barnes D; Eeles RA
    Cancer Res; 2000 Aug; 60(16):4513-8. PubMed ID: 10969800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in BRCA1 and BRCA2 and predisposition to prostate cancer.
    Tischkowitz M; Eeles R;
    Lancet; 2003 Jul; 362(9377):80; author reply 80. PubMed ID: 12853213
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of germline mutations in the BRCA1/2 and mismatch repair genes in men ascertained for early-onset and/or familial prostate cancer.
    Maia S; Cardoso M; Paulo P; Pinheiro M; Pinto P; Santos C; Pinto C; Peixoto A; Henrique R; Teixeira MR
    Fam Cancer; 2016 Jan; 15(1):111-21. PubMed ID: 26289772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of
    Pilarski R
    Am Soc Clin Oncol Educ Book; 2019 Jan; 39():79-86. PubMed ID: 31099688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A twofold increase in BRCA mutation related prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathology.
    Giusti RM; Rutter JL; Duray PH; Freedman LS; Konichezky M; Fisher-Fischbein J; Greene MH; Maslansky B; Fischbein A; Gruber SB; Rennert G; Ronchetti RD; Hewitt SM; Struewing JP; Iscovich J
    J Med Genet; 2003 Oct; 40(10):787-92. PubMed ID: 14569130
    [No Abstract]   [Full Text] [Related]  

  • 12. Rapid progression of prostate cancer in men with a BRCA2 mutation.
    Narod SA; Neuhausen S; Vichodez G; Armel S; Lynch HT; Ghadirian P; Cummings S; Olopade O; Stoppa-Lyonnet D; Couch F; Wagner T; Warner E; Foulkes WD; Saal H; Weitzel J; Tulman A; Poll A; Nam R; Sun P; ; Danquah J; Domchek S; Tung N; Ainsworth P; Horsman D; Kim-Sing C; Maugard C; Eisen A; Daly M; McKinnon W; Wood M; Isaacs C; Gilchrist D; Karlan B; Nedelcu R; Meschino W; Garber J; Pasini B; Manoukian S; Bellati C
    Br J Cancer; 2008 Jul; 99(2):371-4. PubMed ID: 18577985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRCA 1/2 gene mutation and gastrointestinal stromal tumours: a potential association.
    Waisbren J; Uthe R; Siziopikou K; Kaklamani V
    BMJ Case Rep; 2015 Jul; 2015():. PubMed ID: 26150619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of genes and cancer survival: pieces of the puzzle.
    Wacholder S; Loukissas JK; Hartge P
    J Natl Cancer Inst; 2007 Jun; 99(12):908-9. PubMed ID: 17565150
    [No Abstract]   [Full Text] [Related]  

  • 15. Male BRCA1 and BRCA2 mutation carriers: a pilot study investigating medical characteristics of patients participating in a prostate cancer prevention clinic.
    Horsburgh S; Matthew A; Bristow R; Trachtenberg J
    Prostate; 2005 Oct; 65(2):124-9. PubMed ID: 15880530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germline mutations of BRCA1 and BRCA2 genes in Turkish breast, ovarian, and prostate cancer patients.
    Manguoğlu E; Güran S; Yamaç D; Colak T; Simşek M; Baykara M; Akaydın M; Lüleci G
    Cancer Genet Cytogenet; 2010 Dec; 203(2):230-7. PubMed ID: 21156238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A breast cancer family from Spain with germline mutations in both the BRCA1 and BRCA2 genes.
    Caldes T; de la Hoya M; Tosar A; Sulleiro S; Godino J; Ibañez D; Martin M; Perez-Segura P; Diaz-Rubio E
    J Med Genet; 2002 Aug; 39(8):e44. PubMed ID: 12161611
    [No Abstract]   [Full Text] [Related]  

  • 18. Prostate Cancer Screening in a New Era of Genetics.
    Cheng HH; Pritchard CC; Montgomery B; Lin DW; Nelson PS
    Clin Genitourin Cancer; 2017 Dec; 15(6):625-628. PubMed ID: 28697982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of 185delAG mutation of the BRCA1 gene and 6174delT mutation of the BRCA2 gene in Ashkenazi Jewish men with prostate cancer.
    Lehrer S; Fodor F; Stock RG; Stone NN; Eng C; Song HK; McGovern M
    Br J Cancer; 1998 Sep; 78(6):771-3. PubMed ID: 9743298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRCA promoter methylation in sporadic versus BRCA germline mutation-related breast cancers.
    Vos S; Moelans CB; van Diest PJ
    Breast Cancer Res; 2017 May; 19(1):64. PubMed ID: 28569220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.